Effects of adjuvant aromatase inhibitors on bone mineral density observations from clinical practice

被引：0
|
作者：
Hopkins, S. [1 ]
Dent, S. [1 ]
Verma, S. [1 ]
机构：
[1] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70816-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] Impact of adjuvant aromatase inhibitors on bone mineral density in breast cancer patients
    Lai, C. N.
    Correa, P. D.
    Alhasso, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Effects of Aromatase inhibitors on bone mineral density and trabecular bone score in patients with breast cancer
    Dabbagh, V.
    Shandiz, F. Homaee
    Kermani, A. Taghizadeh
    Javan, F. Nesari
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S465 - S465
  • [3] Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients
    Berruti, Alfredo
    Tucci, Marcello
    Mosca, Alessandra
    Vana, Federica
    Ardine, Mara
    Dogliotti, Luigi
    Angeli, Alberto
    Bertoldo, Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1455 - 1456
  • [4] Adjuvant aromatase inhibitors in early breast cancer - toxicity and adherence. Important observations in clinical practice
    Dent, S. F.
    Hopkins, S.
    Di Valentin, T.
    Verreault, J.
    Vandermeer, L.
    Verma, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S111 - S111
  • [5] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Markopoulos, Christos
    [J]. BREAST CANCER RESEARCH, 2010, 12 (04)
  • [6] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Christos Markopoulos
    [J]. Breast Cancer Research, 12
  • [7] BONE MINERAL DENSITY IN PATIENTS WITH AROMATASE INHIBITORS COMPARED TO POSTMENOPAUSAL OSTEOPOROSIS
    Oncu, J.
    Kuran, B.
    Sen, N.
    Yilmaz, F.
    Ercalik, C.
    Dogu, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S476 - S477
  • [8] Bone mineral density in women with breast cancer and the impact of aromatase inhibitors
    Saleh, B.
    Gronland, N.
    Singer, J.
    Bradpiece, H.
    Patel, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 384 - 385
  • [9] Genetic determinants of bone mineral density loss in Aromatase inhibitors treatment
    Rodriguez-Sanz, Maria
    Prieto-alhambra, Daniel
    Servitja-Tormo, Sonia
    Torres-Del-Pliego, Elisa
    Mellibovsky, Leonardo
    Garrigos, Laia
    Garcia-Giralt, Natalia
    Diez-Perez, Adolfo
    Tusquets, Ignacio
    Nogues, Xavier
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [10] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Khachidze, N.
    Giorgadze, E.
    Tsagareli, M.
    Dolidze, N.
    Sharikadze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S237 - S238
12345